GFC Life Science Co Ltd recorded four insider transactions over the past ninety days, all involving Representative Director Kang Hee Cheol. These acquisitions totaled 5,740,958 KRW in purchases. The stock price currently sits near its fifty-two-week low, reflecting a two percent decline during this period without a recent earnings report to provide additional context.